Home · Stock · CMPS

CMPS Compass Pathways PLC

Which ETFs hold CMPS? Compass Pathways PLC is held by 1 fund tracked by ETFpeek.

Held by 1 fund todayData as of 9 Oct 2026
HealthcareMedical Care Facilities
$11.47
+84.4% 1y
$4.8852-week range$15.87
Market cap
$1.6B
3-month
-15.9%
CEO
Mr. Kabir Kumar Nath M.A., M.B.A.
Revenue · last 4 qtrs

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Provider

Currently Held By

ARK
ARKG
ARK Genomic Revolution ETF
Weight in fund2.57%
Shares held4,591,088
Market value$52.7M
View fund →
Not held by the selected provider.
last 90 days
No notable insider activity in the last 90 days. Show all 1 trades
Net flow (90d):−$67K·0 BUY / 1 SELL·showing all trades
DatePersonActionPlanSharesValueScore i
3 Aug 2026
Kabir Nath
CEO & Executive Director
SELLVested (RSU)5,962$67K0
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic
10 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
27 Jul 2026ARKGBUYAdded+107,130+0.03%2.34%
24 Jul 2026ARKGBUYAdded+31,016-0.03%0.71%
23 Jul 2026ARKGBUYAdded+42,088+0.06%0.96%
21 Jul 2026ARKGBUYAdded+238,047+0.12%5.47%
20 Jul 2026ARKGBUYAdded+101,793+0.07%2.47%
17 Jul 2026ARKGBUYAdded+395,990+0.19%9.95%
13 Jul 2026ARKGBUYAdded+37,822+0.13%1.08%
10 Jul 2026ARKGBUYAdded+46,302-0.10%1.33%
9 Jul 2026ARKGBUYAdded+28,447+0.26%0.83%
8 Jul 2026ARKGBUYAdded+191,070+0.23%5.55%
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds